Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.
(Studio: Peter Jennings) Report introduced.
(DC: George Strait) Announcement by France of its approval of abortion pill reported; details given of RU 486 pill, diagram shown. [National Right to Life spokesperson Dr. Richard GLASGOW - calls RU 486 a "death pill."] [Pill user Dominique DELROISSE - comments.] [French physician Dr. Etienne-Emile BEAULIEU - describes use of pill.] Side effects of pill noted. [DELROISSE - comments.] Impt. of drug to Third World explained. [Pop. Council Dr. Irving SPITZ - estimates deaths from inadequately performed abortions.] Opposition to drug from anti-abortion groups noted. [GLASGOW - promises boycott against company getting into abortion drug business] Upjohn Company recalled stopping research of RU 486.
- Jennings, Peter;
- Strait, George
Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.
Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:
- You may request a loan of this video by registering on our website and placing an order.
- You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
- If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.
If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.